Metamizole as pain treatment in patients with chronic pancreatitis, a multicenter, randomized, double-blind, placebo-controlled, superiority trial
Phase 1
Active, not recruiting
- Conditions
- Chronic pancreatitisMedDRA version: 20.1Level: LLTClassification code: 10009093Term: Chronic pancreatitis Class: 10017947Therapeutic area: Diseases [C] - Digestive System Diseases [C06]
- Registration Number
- CTIS2023-504143-14-00
- Lead Sponsor
- Stichting Radboud University Medical Center
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Not Recruiting
- Sex
- All
- Target Recruitment
- 76
Inclusion Criteria
Confirmed chronic pancreatitis, Abdominal pain typical for chronic pancreatitis (i.e. dull epigastric pain), NRS = 3, = 3 days/week for two weeks
Exclusion Criteria
Endoscopic or surgical intervention < 3 months prior to inclusion, Expected endoscopic or surgical intervention for CP within trial duration (6 weeks), Usage of more than 90 morphine milligram equivalents per day, Active use of metamizole at inclusion, Contra-indications to metamizole, Pancreatic carcinoma, •Start of amitriptyline, pregabalin or gabapentin less than 6 weeks prior to inclusion
Study & Design
- Study Type
- Interventional clinical trial of medicinal product
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method